Copper Rock Capital Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Copper Rock Capital Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-9,103	Closed	-$943K	–	225
2014 Q1	$943K	Buy	9,103 +59	+0.7%	+$6.04K	0.09%	153
2013 Q4	$813K	Buy	+9,044	New	+$721K	0.08%	164

Other funds holding SLXP

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Copper Rock Capital Partners's SLXP Position: Q2 2014 in Review

Copper Rock Capital Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2014, closing a stake of 9,103 shares — an estimated $943K sold.

Copper Rock Capital Partners first reported a position in SLXP in Q4 2013 and held it in 2 quarters. The position peaked at $943K in Q1 2014. 308 funds tracked by Wall St. Rank hold SLXP as of Q2 2014.

Copper Rock Capital Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2014 after selling out during the quarter.
Copper Rock Capital Partners sold 9,103 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2014, an estimated $943K.
Copper Rock Capital Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 2 quarters.
Copper Rock Capital Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $943K in Q1 2014.
308 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2014.

Based on Copper Rock Capital Partners's 13F filing for Q2 2014, filed 8 Jul 2014.